Why the study?
Does the MLPA method reliably detect deletions and duplications in the dystrophin gene in patients with Duchenne's and Becker muscular dystrophy?
Observational (n=112)
Does the MLPA method reliably detect deletions and duplications in the dystrophin gene in patients with Duchenne's and Becker muscular dystrophy?
The MLPA method is a reliable technique for detecting deletions and duplications in the dystrophin gene in both affected males and female carriers of Duchenne and Becker muscular dystrophy.
Duchenne's muscular dystrophy and Becker muscular dystrophy (BMD) are X-linked recessive disorders caused by mutations in the dystrophin gene. In this project, 100 unrelated male patients were initially screened for deletions in the dystrophin gene by multiplex polymerase chain reaction, of whom 52 were positive. We performed the multiplex ligation-dependent probe amplification (MLPA) method on 43 of the remaining 48 patients, as well as 12 females suspected to be carriers, to detect deletions and duplications of their dystrophin gene. The MLPA method found deletions and duplications in 8 unidentified male patients. Sequencing revealed that in one case the deletion detected was a point mutation. One of 12 females was heterozygous for deletion of exons 49 and 50. In conclusion, the MLPA method proved to be reliable for studying affected males as well as female carriers.
No takes yet. Share an insight, caveat, or question.
Khordadpoor-Deilamani et al. (2011) conducted an observational in Duchenne's muscular dystrophy and Becker muscular dystrophy (n=112). Multiplex ligation-dependent probe amplification (MLPA) was evaluated on Detection of deletions and duplications in the dystrophin gene.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: